Forest Tudorza Pressair Approval For COPD Includes Post-marketing CV Safety Study
This article was originally published in The Pink Sheet Daily
Executive Summary
The twice-daily aclidinium, a long-acting antimuscarinic agent, should be available to wholesalers in the fourth quarter.